7RLY image
Entry Detail
PDB ID:
7RLY
Title:
Antibody 2F2 in complex with P. vivax CSP peptide DRAAGQPAGDRADGQPA
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-07-26
Release Date:
2022-01-26
Method Details:
Experimental Method:
Resolution:
2.67 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:2F2 Fab heavy chain
Chain IDs:C (auth: A), E (auth: C), G (auth: E)
Chain Length:224
Number of Molecules:3
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:2F2 Fab light chain
Chain IDs:B, D, F
Chain Length:221
Number of Molecules:3
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:peptide from Circumsporozoite protein variant VK210
Chain IDs:A (auth: P), H (auth: R), I (auth: Q)
Chain Length:17
Number of Molecules:3
Biological Source:Plasmodium vivax
Primary Citation
Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats.
Elife 11 ? ? (2022)
PMID: 35023832 DOI: 10.7554/eLife.72908

Abstact

Malaria is a global health burden, with Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) responsible for the majority of infections worldwide. Circumsporozoite protein (CSP) is the most abundant protein on the surface of Plasmodium sporozoites, and antibodies targeting the central repeat region of CSP can prevent parasite infection. Although much has been uncovered about the molecular basis of antibody recognition of the PfCSP repeats, data remains scarce for PvCSP. Here, we performed molecular dynamics simulations for peptides comprising the PvCSP repeats from strains VK210 and VK247 to reveal how the PvCSP central repeats are highly disordered, with minor propensities to adopt turn conformations. Next, we solved eight crystal structures to unveil the interactions of two inhibitory monoclonal antibodies (mAbs), 2F2 and 2E10.E9, with PvCSP repeats. Both antibodies can accommodate subtle sequence variances in the repeat motifs and recognize largely coiled peptide conformations that also contain isolated turns. Our structural studies uncover various degrees of Fab-Fab homotypic interactions upon recognition of the PvCSP central repeats by these two inhibitory mAbs, similar to potent mAbs against PfCSP. These findings augment our understanding of host-Plasmodium interactions and contribute molecular details of Pv inhibition by mAbs to unlock structure-based engineering of PvCSP-based vaccines.

Legend

Protein

Chemical

Disease

Primary Citation of related structures